about
Combination antiretroviral studies for patients with primary biliary cirrhosisOsteoarthritis prevalence and modifiable factors: a population study.Impact of a 3-year multi-centre community-based intervention on risk factors for chronic disease and obesity among free-living adults: the Healthy Alberta Communities study.Walking and type 2 diabetes risk using CANRISK scores among older adults.Measuring the progress of capacity building in the Alberta Policy Coalition for Cancer Prevention.Healthy Alberta Communities: impact of a three-year community-based obesity and chronic disease prevention intervention.Evaluation of classical and novel autoantibodies for the diagnosis of Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome (PBC-AIH OS).Examining the Promotion of Healthy Eating among Exercise Specialists: A Cross-sectional StudySelection of Quality Indicators in IBD: Integrating Physician and Patient PerspectivesValidation of Risk Scoring Systems in Ursodeoxycholic Acid-Treated Patients With Primary Biliary CholangitisSevere vitamin D deficiency is a prognostic biomarker in autoimmune hepatitis
P50
Q26772310-2538851B-8F8C-4C90-AFD6-2837A83DC277Q35856067-717AD48D-8C00-47EE-8132-4C5604C7338FQ35992837-E9030334-B754-4832-B898-29904E6E3AF2Q39142077-FD8D5737-CAC2-4B6A-842E-F1642009418FQ39295729-908C65AD-111D-4516-8433-3481F5BE2E38Q44213117-171AC30E-8AB4-4FF7-BC8C-949AD37E0712Q52648759-3B647E27-9FFE-431B-B51A-BF0AFBFEB6F7Q60764190-47B81739-0839-47CA-B425-CAB88E93CC30Q91249827-5B3A9A4C-7A3F-492A-9D8C-069CC2BC61BEQ93040660-EED6C33D-625F-4AC3-808C-80FA945B3016Q93365560-0E8B7D53-ABE3-4BF4-ADDF-62968D1AA576
P50
description
investigador
@es
researcher
@en
name
Ellina Lytvyak
@en
type
label
Ellina Lytvyak
@en
prefLabel
Ellina Lytvyak
@en
P31
P496
0000-0001-5651-9010